
The Foundation awarded up to $5.6M to Microbion Corp. to develop an inhaled antibiotic that could help break down biofilms and kill drug-resistant bacteria in people with #cysticfibrosis. #CFresearch on.cff.org/2zvbSpL
Ann Field
53 posts


The Foundation awarded up to $5.6M to Microbion Corp. to develop an inhaled antibiotic that could help break down biofilms and kill drug-resistant bacteria in people with #cysticfibrosis. #CFresearch on.cff.org/2zvbSpL

Yesterday, we took our Infection Research Initiative steering committee meeting virtual! The committee discussed infection prevalence and the impact of Trikafta, the current infection research landscape, and made recommendations on research gaps, opportunities, and priorities.




Here’s a useful overview of the likely scenarios that the world will be facing in the coming months while managing this pandemic. So much depends on our ability to make good decisions going forward along with our ability to remain resilient. theatlantic.com/health/archive…




While addressing COVID-19 we will also continue to work on the many other challenges that people with CF face. cff.org/News/News-Arch…

Your voice makes a difference! After last month’s March on the Hill, 7️⃣ 3️⃣ members of Congress signed a letter asking their colleagues to help sustain a robust antibiotics pipeline. Thank you to everyone who helped make the #cysticfibrosis community’s voice heard. #CFadvocacy




An incredible experience being a patient who recieved #phagetherapy speaking to a roomful of #phage researchers at #phagesfutures. With this momentum, more patients will be participating in clinical trials and receiving this therapy soon! #phagedirectory





